Literature DB >> 16352806

Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.

Aukje W Zimmerman1, Ben Joosten, Ruurd Torensma, Jane R Parnes, Frank N van Leeuwen, Carl G Figdor.   

Abstract

Interactions between T cells and antigen-presenting cells (APCs) are the first step in the induction of an adaptive immune response. Here, we show that CD6 and its ligand activated leukocyte cell adhesion molecule (ALCAM) are actively recruited to the antigen-induced dendritic cell (DC)-T-cell contact zone. Moreover, ALCAM-blocking antibodies interfere with DC-T-cell conjugate formation, demonstrating that CD6-ALCAM binding is essential for stable T-cell-APC contact. We now demonstrate that besides their role in establishing initial contacts, CD6-ALCAM interactions are also required during the proliferative phase of the T-cell response; the presence of CD6-blocking antibodies or recombinant ALCAM-Fc proteins results in a strong and sustained inhibition of T-cell proliferation. Furthermore, simultaneous crosslinking of CD6 and CD3 induces enhanced proliferation and transcriptional activity to a similar level as observed after CD3 and CD28 co-crosslinking, demonstrating that CD6 is an important costimulatory molecule. The stability of ALCAM-CD6 binding, which contrasts with transient homotypic ALCAM-ALCAM interactions, further supports the long-lasting effects observed on T-cell proliferation. Taken together, we demonstrate that CD6 and ALCAM form a key adhesive receptor-ligand pair that is not only involved in early DC-T-cell binding but also in sustaining DC-induced T-cell proliferation long after the initial contact has been established.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352806     DOI: 10.1182/blood-2005-09-3881

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  72 in total

1.  Alcama mediates Edn1 signaling during zebrafish cartilage morphogenesis.

Authors:  Priya Choudhry; Deepa Joshi; Birgit Funke; Nikolaus Trede
Journal:  Dev Biol       Date:  2010-11-10       Impact factor: 3.582

2.  CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.

Authors:  P Nair; R Melarkode; D Rajkumar; E Montero
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

3.  Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis.

Authors:  Marc-André Lécuyer; Olivia Saint-Laurent; Lyne Bourbonnière; Sandra Larouche; Catherine Larochelle; Laure Michel; Marc Charabati; Michael Abadier; Stephanie Zandee; Neda Haghayegh Jahromi; Elizabeth Gowing; Camille Pittet; Ruth Lyck; Britta Engelhardt; Alexandre Prat
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

4.  Activated leucocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy.

Authors:  Y S Kim; M N Kim; K E Lee; J Y Hong; M S Oh; S Y Kim; K W Kim; M H Sohn
Journal:  Clin Exp Immunol       Date:  2018-02-20       Impact factor: 4.330

5.  ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9.

Authors:  Alvaro Gilsanz; Lorena Sánchez-Martín; María Dolores Gutiérrez-López; Susana Ovalle; Yesenia Machado-Pineda; Raquel Reyes; Guido W Swart; Carl G Figdor; Esther M Lafuente; Carlos Cabañas
Journal:  Cell Mol Life Sci       Date:  2012-09-30       Impact factor: 9.261

6.  Immunological evaluation of rheumatoid arthritis patients treated with itolizumab.

Authors:  Lazaro E Aira; Patricia Hernández; Dinorah Prada; Araceli Chico; Jorge A Gómez; Zuyén González; Karla Fuentes; Carmen Viada; Zaima Mazorra
Journal:  MAbs       Date:  2015-10-15       Impact factor: 5.857

Review 7.  Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.

Authors:  Ariana von Lersner; Lenny Droesen; Andries Zijlstra
Journal:  Clin Exp Metastasis       Date:  2019-02-18       Impact factor: 5.150

8.  Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.

Authors:  Shingo Inaguma; Jerzy Lasota; Zengfeng Wang; Piotr Czapiewski; Renata Langfort; Janusz Rys; Joanna Szpor; Piotr Waloszczyk; Krzysztof Okoń; Wojciech Biernat; Hiroshi Ikeda; David S Schrump; Raffit Hassan; Markku Miettinen
Journal:  Hum Pathol       Date:  2017-08-12       Impact factor: 3.466

9.  CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal.

Authors:  Gospel Enyindah-Asonye; Yan Li; Wei Xin; Nora G Singer; Neetu Gupta; John Fung; Feng Lin
Journal:  J Biol Chem       Date:  2016-12-01       Impact factor: 5.157

10.  Alcam regulates long-term hematopoietic stem cell engraftment and self-renewal.

Authors:  Robin Jeannet; Qi Cai; Hongjun Liu; Hieu Vu; Ya-Huei Kuo
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.